Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products

@article{Sehovic2010RiskOV,
  title={Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products},
  author={Naida Sehovic and Katherine P. Smith},
  journal={Annals of Pharmacotherapy},
  year={2010},
  volume={44},
  pages={898 - 903}
}
OBJECTIVE: To review primary literature regarding the risk of venous thromboembolism (VTE) in users of combined oral contraceptives (COCs) containing drospirenone compared to COCs containing other progestins. DATA SOURCES: A literature search of MEDLINE and EMBASE (1950-January 2010) was conducted using the following search terms: VTE, thrombosis, thromboembolism, COC, combined hormonal contraceptives, drospirenone, Yasmin, and Yaz. Additional references were retrieved from reference citations… Expand
View on SAGE
ncbi.nlm.nih.gov
20 Citations
Highly Influential Citations
2
Background Citations
5

20 Citations

Citation Type

Citation Type

Oral contraceptive use for the primary prevention of ovarian cancer.
Two cases of venous sinus thrombosis in women taking the oral contraceptive pill, Yaz (dropirenone/ ethinyl estradiol), and review of the literature
Deep Vein Thrombosis due to Oral Contraceptive use in a Young Female
Drospirenone‐Containing Oral Contraceptives and Risk of Adverse Outcomes After Myocardial Infarction
  • C. Karabay, G. Kocabay, +9 authors C. Kirma
  • Medicine
  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2013
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.
Pulmonary embolism in young people. Trends in Germany from 2005 to 2011.
Estrogen and thrombosis: Controversies and common sense
  • T. Deloughery
  • Medicine
  • Reviews in Endocrine and Metabolic Disorders
  • 2011
Progestins in Combined Contraceptives
Emergency Evaluation for Pulmonary Embolism, Part 1: Clinical Factors that Increase Risk.
Disproportional increase of pulmonary embolism in young females in Germany: trends from 2005 to 2014
...
1
2
...

References

SHOWING 1-10 OF 23 REFERENCES
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease.
Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate
Oral contraceptives and venous thromboembolism: old questions revisited
  • J. Dinger
  • Medicine
  • Journal of Family Planning and Reproductive Health Care
  • 2009
Coagulation effects of oral contraception.
  • J. Bonnar
  • Medicine
  • American journal of obstetrics and gynecology
  • 1987
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen.
Yasmin and venous thromboembolism: new case reports.
...
1
2
3
...